Clinical study of external application of Xuantong Powder combined with focused ultrasound ablation (FUA) in pain patients with advanced liver cancer
外敷癌痛散联合聚焦超声消融（FUA）对晚期肝癌疼痛患者的临床研究

摘要

目的 观察外敷癌痛散联合聚焦超声消融（FUA）对晚期肝癌疼痛患者的效果。方法 筛选2022年8月至2023年8月期间本院行FUA治疗晚期肝癌患者共26例。依照入院号随机分为两组，各13例。对照组仅接受FUA治疗，观察组在此基础联合外敷癌痛散。对比两组疼痛程度、生活质量；评价疼痛缓解效果。结果 观察组较对照组，其疼痛总缓解率高于对照组（P＜0.05）。对比数字分级法（NRS），观察组治疗后1d、3d、6d时得分均低于对照组（P＜0.05）。对比癌症患者生命质量核心量表（QLQ-C30）得分，观察组高于对照组（P＜0.05）。结论 外敷癌痛散联合FUA对晚期肝癌患者癌痛有确切缓解作用，且有助于生活质量改善。

Abstract

Objective To observe the effect of external application of Xuantong SAN combined with focused ultrasound ablation (FUA) on pain patients with advanced liver cancer.
Methods A total of 26 patients with advanced liver cancer treated with FUA in our hospital from August 2022 to August 2023 were selected. According to the admission number, the patients were randomly divided into two groups, 13 cases each. The control group only received FUA treatment, and the observation group was combined with external application of cancertong powder on this basis. The pain degree and quality of life of the two groups were compared. Evaluate the pain relief effect.
Results The total pain relief rate of observation group was higher than that of control group (P < 0.05). Compared with digital grading (NRS), the scores of the observation group were lower than those of the control group at 1d, 3d and 6d after treatment (P < 0.05). The score of the Core Quality of Life Scale (QLQ-C30) in the observation group was higher than that in the control group (P < 0.05).
Conclusion   External application of Xuantong powder combined with FUA can relieve cancer pain and improve quality of life in patients with advanced liver cancer.